Contact us at the Senergene Solutions office nearest to you or submit a business inquiry online.
2020
-
Chinese authorities confirm the case of bubonic plague in Inner Mongolia
- July 9, 2020
- Posted by: Senergene
- Category: News
No CommentsThe bubonic plague, a disease that caused one of the most deadly pandemics in history, has reappeared in a case in Inner Mongolia. The case was officially diagnosed and confirmed on Tuesday, July 7th, 2020, in Bayannur, and the patient is being isolated and treated in a hospital. The patient is in stable condition. As
-
How to Succeed at Your Job When There Is No Office
- July 8, 2020
- Posted by: Senergene
- Category: News
During the Coronavirus Pandemic, many of us have had to adapt to working from home and overcome the many challenges that can come with it. Many people have had to manage to work from home with a full household, while others have had to find the time to work and be their children’s at-home teachers. -
Worrisome Covid-19 Mutation Is More Contagious
- July 8, 2020
- Posted by: Senergene
- Category: News
In a recent study published in the Journal Cell on July 2nd, 2020, researchers discussed a mutation they found, called “D614G”, that causes a change in the “spike” protein of the SARS-CoV-2 virus (i.e., COVID-19). In essence, spike proteins are what allow many illnesses, including coronavirus, to penetrate human cells and cause infections. Therefore, researchers
-
Gilead announces long-awaited price for Covid-19 drug remdesivir
- July 2, 2020
- Posted by: Senergene
- Category: News
Gilead Sciences, Inc., an American biopharmaceutical company headquartered in Foster City, announced its pricing for the use of the drug remdesivir, an intravenous treatment for COVID-19 patients. According to data analysis from a randomized, controlled trial involving 1063 patients, conducted by the National Institute of Allergy and Infectious Disease, remdesivir was better than the placebo
-
Serious coronavirus-linked condition hit 285 U.S. children
- July 2, 2020
- Posted by: Senergene
- Category: News
This Monday, June 29th, 2020, the New England Journal of Medicine published a report on a new coronavirus-linked condition found in 285 U.S. children. The condition, known as a multisystem inflammatory syndrome, caused six deaths amongst the 285 children, and the remainder recovered. Although the death rate of the virus is low, the potential long-term effects
-
A Second Wave of COVID-19
- June 12, 2020
- Posted by: Senergene
- Category: News
Second wave of COVID-19? Coronavirus outbreaks emerging in U.S. states reopening: Arizona, Florida, Texas, California and more | Fortune fortune.com A fresh onslaught of the coronavirus is bringing challenges for residents and the economy in pockets across the U.S. The localized surges have raised alarms among experts even as they’re masked … SUMMARY As the
-
KFF Health Tracking poll- May 2020
- June 12, 2020
- Posted by: Senergene
- Category: News
KFF Health Tracking Poll – May 2020 – Health and Economic Impacts – 9474 | KFF www.kff.org Impact of Coronavirus on Personal Health, Economic and Food Security, and Medicaid Key Findings: Amidst the coronavirus pandemic, Americans are deferring medical care. Nearly half of adults (48%) SUMMARY The Kaiser Family Foundation (KFF), a non-profit organization focusing
-
Supply of Remdesivir for COVID-19 Running Out
- June 12, 2020
- Posted by: Senergene
- Category: News
Hospitals frustrated by Remdesivir supply The US government’s current supply of remdesivir, the only drug known to work against Covid-19, will run out at the end of the month, Dr. Robert Kadlec, a US Department of Health and Human Services official, told CNN. SUMMARY As COVID-19 continues to spread around the U.S., medical practitioners and
-
Plasma Therapy Aids Recovery in Critically Ill COVID-19 Patients
- June 11, 2020
- Posted by: Senergene
- Category: News
At this point, all Americans are used to the COVID-19 pandemic overwhelming our healthcare news. Physicians and scientists around the world are working on a cure to the virus, but no treatments have been proven thus far. A recent report published in the American Journal of Pathology discusses plasma transfusions from recovered Coronavirus patients as